Bezwada Biomedical

Bezwada Biomedical is an innovation-driven biomaterials company with a proprietary platform of absorbable polymers, including polyurethanes, polyoxaesters, and modified PLGAs. The company targets applications in drug delivery, medical device coatings (e.g., stents), surgical sealants/adhesives, and 3D bioprinting. Led by its founder, a prolific inventor with a proven commercial track record (e.g., Monocryl® suture), the company is ISO 13485 certified, has secured NSF SBIR grants, and is advancing products like the TissuBond™ surgical sealant towards commercialization.

Proprietary platform of absorbable (bioabsorbable) polymers including tunable polyurethanes, polyoxaesters, advanced PLGA copolymers, and bioinks for 3D printing. Focus on materials that degrade safely in the body with superior, customizable properties for medical applications.

Bezwada competes in the specialty biomaterials space against large chemical companies (e.g., Corbion, Evonik, BASF) that supply standard polymers like PLGA, as well as other biotech startups developing novel absorbable materials. Its differentiation lies in its founder's unparalleled track record, a deep IP portfolio in absorbable polyurethanes, and a focus on complete tunability and performance beyond traditional options.